AUDREY HUBLER: Open Payments
NPI 1831754720 · SOUTH WEST CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 16 payments from 10 companies in 2025. Trend: 2023 $44 · 2024 $221 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $46 |
| Dexcom, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: JARDIANCE, KISUNLA, BREZTRI, Dexcom G6 Transmitter, YUPELRI, GEMTESA, REPATHA, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
